Alimatravir is an investigational once-a-month oral PrEP currently in Phase III trials. It is not yet available in South Africa and would need SAHPRA approval.
Johannesburg residents with bypassed prepaid meters are facing severe consequences as City Power intensifies its crackdown on illegal electricity connections. In less than a week, hundreds...